Molecular Pharmacology Program
The Michael Kharas Lab
Research

The Kharas lab is working to identify critical pathways in both normal and leukemic hematopoietic cells.
Inside My Lab: Michael Kharas

Featured News
Publications
People

Michael G. Kharas, PhD
- Cancer biologist Michael Kharas studies RNA regulators of self-renewal in both normal and leukemic hematopoiesis.
- PhD, University of California Irvine
- [email protected]
- Email Address
Members





- BS, Portland State University








Research Scholar

Research Scholars



Graduate Student

Associate Member

Research Fellow

Research Scholars

Research Associate




Administrative Assistant








Lab Alumni

Administrative Assistant
Research Fellow

Graduate Student at Weill Cornell
Research Technician
Graduate Student

Research Technician

Research Technician
Lab Intern

Biotech

Technician, Ly Vu Lab, BC Cancer Agency

Graduate Student at University of California, San Diego

Research Scholar
Graduate Student
Lab Intern

Graduate Student

Medical Student at Albert Einstein
Research Technician

Research Technician

Assistant Professor, BC Cancer Agency
Lab Affilations
Achievements
- Leukemia and Lymphoma Society Career Development Award (2017)
- Alex Lemonade Stand Foundation ‘A’ Award (2016)
- American Society of Hematology Junior Faculty Scholar Award (2011)
- Kimmel Scholar Award (2013)
- V-Scholar Award (2013)
Open Positions
Career Opportunities
Research Technician
As a Research Technician you will perform research activities in collaboration with internal/external personnel to complete science-based projects. You will normally receive detailed instructions while making observations, analyzing data and interpreting results according to laboratory procedures. The Research Technician will provide support to all technical/research staff and postdocs.
Get in Touch
-
Lab Head Email
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Michael G. Kharas discloses the following relationships and financial interests:
-
28-7 Therapeutics
Provision of Services (uncompensated)
-
Accent Therapeutics
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].